TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-58.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$50.2M
AUM Growth
-$81.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$2.7M
2
+$83.2K

Top Sells

1
+$6.5M
2
+$6.49M
3
+$5.99M
4
THC icon
Tenet Healthcare
THC
+$5.61M
5
ABT icon
Abbott
ABT
+$4.91M

Sector Composition

1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1
Viatris
VTRS
$18.1B
$6.66M 13.27%
675,000
-575,000
BDX icon
2
Becton Dickinson
BDX
$50.2B
$6.46M 12.88%
25,000
+10,000
MDRX
3
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.72M 11.39%
435,000
-495,000
MCK icon
4
McKesson
MCK
$121B
$4.78M 9.53%
11,000
-3,000
STRM
5
DELISTED
Streamline Health Solutions
STRM
$4.77M 9.51%
328,725
COLL icon
6
Collegium Pharmaceutical
COLL
$1.32B
$4.13M 8.24%
185,000
-190,000
PHR icon
7
Phreesia
PHR
$740M
$4.02M 8.01%
215,000
-75,000
ANGO icon
8
AngioDynamics
ANGO
$468M
$3.47M 6.92%
475,000
+10,000
TCMD icon
9
Tactile Systems Technology
TCMD
$657M
$3.36M 6.7%
239,222
-60,778
ATRC icon
10
AtriCure
ATRC
$1.54B
$1.75M 3.49%
40,000
-45,000
SNY icon
11
Sanofi
SNY
$115B
$1.61M 3.21%
30,000
-65,000
THC icon
12
Tenet Healthcare
THC
$20.4B
$1.32M 2.63%
20,000
-75,000
SIBN icon
13
SI-BONE Inc
SIBN
$681M
$1.06M 2.12%
50,000
-150,000
CERS icon
14
Cerus
CERS
$486M
$1.05M 2.1%
650,000
-1,100,000
ALKS icon
15
Alkermes
ALKS
$4.99B
– –
-100,000
BIO icon
16
Bio-Rad Laboratories Class A
BIO
$7.55B
– –
-2,000
ABT icon
17
Abbott
ABT
$198B
– –
-45,000
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-75,000
DCGO icon
19
DocGo
DCGO
$67.5M
– –
-135,000
DXCM icon
20
DexCom
DXCM
$28.4B
– –
-16,000
INMD icon
21
InMode
INMD
$864M
– –
-75,000
IRWD icon
22
Ironwood Pharmaceuticals
IRWD
$581M
– –
-225,000
KVUE icon
23
Kenvue
KVUE
$36.2B
– –
-1,000
OEF icon
24
iShares S&P 100 ETF
OEF
$28.6B
– –
0
RDNT icon
25
RadNet
RDNT
$5.82B
– –
-140,000
1
2